Sitemap
December 24, 2016 Articles
Filter by Available Specialty
- Centrexion Therapeutics announces results from study on injection for relief of OA knee pain
- FDA clears integration of diabetes management technology
- GRAALL 2005: Age 55 years may be limit for pediatric regimens in ALL
- ID fellowship match results improve following implementation of ‘All-In Policy’
- PUBLICATION EXCLUSIVE: Multiple surgical options available to correct dislocated IOLs
- Registry launched for study of cholesterol management